{"id":3699,"date":"2019-01-31T09:05:09","date_gmt":"2019-01-31T17:05:09","guid":{"rendered":"http:\/\/depts.washington.edu\/diabetes\/?p=3699"},"modified":"2019-01-31T09:05:09","modified_gmt":"2019-01-31T17:05:09","slug":"http-r-smartbrief-com-resp-leqxcehuifdgnexeciegiwcicndgcdformatmultipart-2","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/diabetes\/http-r-smartbrief-com-resp-leqxcehuifdgnexeciegiwcicndgcdformatmultipart-2\/","title":{"rendered":"Weight fluctuations tied to worse diabetes outcomes, study finds"},"content":{"rendered":"<style type=\"text\/css\"><\/style>\n<section class=\"kc-elm kc-css-992562 kc_row\">\n<div class=\"kc-row-container  kc-container\">\n<div class=\"kc-wrap-columns\">\n<div class=\"kc-elm kc-css-3450460 kc_col-sm-12 kc_column kc_col-sm-12\">\n<div class=\"kc-col-container\">\n<div class=\"kc-elm kc-css-1450632 kc_text_block\">\n<p>Researchers analyzed data from the FDA Adverse Event Reporting System between April 2005 and September 2017 and found that older diabetes patients who used GLP-1 receptor agonists were not at an increased risk for diabetic retinopathy. The findings in <a class=\"\" href=\"http:\/\/r.smartbrief.com\/resp\/leqXCehuiFDgnexfCieGiwCicNdQNw\" target=\"_blank\" rel=\"noopener\">Diabetes Care<\/a> revealed that 263 of the 389 GLP-1 receptor agonist-related DR events were associated with exenatide, 82 with liraglutide, 28 with dulaglutide and 16 with albiglutide.<\/p>\n<p><span class=\"mobile_wrap\"><a class=\"\" href=\"http:\/\/r.smartbrief.com\/resp\/leqXCehuiFDgnexeCieGiwCicNdgCd?format=multipart\" target=\"_blank\" rel=\"noopener\">Endocrinology Advisor<\/a><span class=\"\"> (1\/1)<\/span><\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Researchers analyzed data from the FDA Adverse Event Reporting System between April 2005 and September 2017 and found that older diabetes patients who used GLP-1 receptor agonists were not at an increased risk for diabetic retinopathy. The findings in Diabetes Care revealed that 263 of the 389 GLP-1 receptor agonist-related DR events were associated with&#8230;  <a class=\"excerpt-read-more\" href=\"https:\/\/depts.washington.edu\/diabetes\/http-r-smartbrief-com-resp-leqxcehuifdgnexeciegiwcicndgcdformatmultipart-2\/\" title=\"Read Weight fluctuations tied to worse diabetes outcomes, study finds\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"link","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-3699","post","type-post","status-publish","format-link","hentry","category-diabetes-related-news","post_format-post-format-link"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/3699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/comments?post=3699"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/3699\/revisions"}],"predecessor-version":[{"id":3703,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/3699\/revisions\/3703"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/media?parent=3699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/categories?post=3699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/tags?post=3699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}